[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"delivery-obstetric\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:delivery-obstetric":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,49,93],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100497921","understanding-the-role-of-doulas-in-supporting-people-with-pmads-100497921",false,"NCT05763537","Understanding the Role of Doulas in Supporting People With PMADs","Inclusion Criteria:\n\n* Participants must be over the age of 18\n* Currently pregnant and between 13 and 26 gestational weeks at the time of enrollment\n* Live in a HRSA-designated rural area of Montana\n\nExclusion Criteria:\n\n* They are under the age of 18\n* Not currently pregnant\n* Not between 13-26 gestational weeks at the time of enrollment\n* If they do not live in a HRSA-designated rural are of Montana.",true,"FEMALE","18 Years",{"count":19,"type":20},75,"ESTIMATED","INTERVENTIONAL",[23],"NA","Detailed Description The doula-led intervention developed during the first phase of this project will be pilot tested for feasibility. Following the recruitment procedures described in the recruitment and retention plan, approximately 75 participants will be enrolled into the study. Twenty-five of the participants will receive regular doula care and 25 of the participants will receive care from a doula trained in the PMAD doula training throughout their pregnancy, childbirth, and postpartum time period, following the intervention procedures developed in Aim 2 of this study. Twenty-five women will not receive care from a doula and will receive perinatal care as usual. Women in all groups will take surveys via REDCap during their enrollment in the intervention, at 1 month postpartum, 3 months, and 6 months postpartum (at the conclusion of the intervention). All participants who receive the PMAD doula intervention will complete checklists after each session with their doula, to assess fidelity to the intervention. Participant communication with their doula via patient notebook will also be assessed for fidelity to the intervention.",[26,27,28,29,30,31,32,33,34,35],"Maternal Health","Pregnancy","Delivery, Obstetric","Self Efficacy","Social Support","Mental Health","Substance-Related Disorders","Postpartum Depression","Depression","Mental Health Services","RECRUITING","2025-11-12",{"date":39,"type":40},"2025-11-14","ACTUAL",{"date":42,"type":40},"2024-11-26",{"date":44,"type":20},"2026-07-31",{"name":46,"class":47},"University of Montana","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":15,"sex":56,"minAge":4,"maxAge":57,"enrollmentInfo":58,"targetDuration":4,"studyType":21,"phases":60,"briefSummary":61,"conditions":62,"keywords":76,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":92},"100609268","infant-microbiota-restoration-with-maternal-microbes-100609268","NCT07212361","Infant Microbiota Restoration With Maternal Microbes","MaMi","Inclusion Criteria:\n\n* Healthy mother and healthy pregnancy\n* Singleton pregnancy,\n* Mothers who speak Finnish or Swedish\n* Mothers who are planning to breastfeed or give breastmilk by bottle to the infant\n* Infants who are expected to be healthy and who will not require BCG vaccination.\n\nExclusion Criteria:\n\n* Participants who lives further than a 2-hour drive from Meilahti, Helsinki, Finland\n* Mothers who are not planning to breastfeed or feed breastmilk by bottle to the infant\n* Mothers who are diagnosed with gestational diabetes, pre-eclampsia or who have been receiving antibiotics during the pregnancy or delivery\n* Premature infants born before the pregnancy week 37\n* Infants, who are born by urgent cesarean section or emergency cesarean section\n* Infants, who receive antibiotics during the first week of life\n* Infants, who are diagnosed with a disease, congenital anomaly or who receive less than 9 Apgar points at 5 minutes.\n* Infants, who receive BCG-vaccine","ALL","50 Years",{"count":59,"type":20},100,[23],"The goal of this clinical trial is to test the ability of different bacterial products in restoring natural gut microbiota in C-section born infants. The main question it aims to answer is:\n\nDo maternally derived strains of bacteria perform better than commercially available probiotic strains in restoring the gut microbiota of C-section born infants? Researchers will compare the gut microbiota of treated infants to that of untreated C-section born infants and untreated vaginally born infants to see if the bacterial treatments cause the microbiota to resemble that of vaginally born infants.\n\nParticipants will be given a bacterial product orally once daily for either one or four weeks and be asked to collect faecal, urine and saliva samples.",[63,64,65,66,67,68,69,70,71,28,72,73,74,27,75],"Infant, Newborn","Gut -Microbiota","Gut Dysbiosis","Cesarean Delivery Affecting Newborn","Cesarean Section","Vaginal Delivery","Gastrointestinal Microbiota","Microbiota, Cesarean Section, Probiotics, Dysbiosis","Feces","Microbiota","Microbiology","Humans","Neonate",[77,78,79,80,81,82],"Infant","newborn","cesarean section","neonate","restore","gut microbiota","2025-09-30",{"date":85,"type":40},"2025-10-08",{"date":87,"type":40},"2025-07-17",{"date":89,"type":20},"2035-12-31",{"name":91,"class":47},"University of Helsinki",2,{"id":94,"slug":95,"hasResults":11,"nctId":96,"briefTitle":97,"officialTitle":98,"acronym":99,"eligibilityCriteria":100,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":101,"enrollmentInfo":102,"targetDuration":4,"studyType":21,"phases":104,"briefSummary":105,"conditions":106,"keywords":108,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":48},"100555025","comparison-between-two-medical-devices-for-labor-induction-after-previous-c-section-100555025","NCT06506721","Comparison Between Two Medical Devices for Labor Induction After Previous C-section","Balloon Catheter vs. Hygroscopic Cervical Dilator for Labour Induction After Previous Caesarean Section: an Open Prospective Randomized Controlled Trial","DiBal","Inclusion Criteria:\n\n* All women \\>= 18years old with a previous CS and an indication of labour induction, between 24-42 weeks of pregnancy.\n* Modified Bishop-Score \\\u003C 6\n* Informed consent\n\nExclusion criteria:\n\n* More than 1 CS\n* Premature rupture of membranes\n* Vaginal infection\n* Intrauterine fetal demise\n* Twin pregnancy\n* Contraindication against labour induction or vaginal delivery\n* Vaginal bleeding\n* Simultaneous external administration of prostaglandins planned\n* Placenta praevia, vasa praevia or placenta accreta spectrum\n* Transverse fetal orientation\n* Prolapsed umbilical cord\n* Prior hysterotomy, classic uterine incision, myomectomy or any other full thickness uterine incision (except C-section)\n* Pelvic structural anomaly\n* Active genital herpes infection\n* Invasive cervical cancer\n* Abnormal fetal heart rate pattern\n* Breech presentation\n* Maternal heart disease\n* Polyhydramnios\n* Presentic part above the pelvic inlet\n* Severe maternal hypertension","60 Years",{"count":103,"type":20},137,[23],"The objective of the study ist to compare the Dilapan-S and the Cook Ballon device for the mechanical induction of labour in women with a previous C-section. There is currently lack of data regarding this comparison of the two methods for mechanical labour induction in this patient collective. Any method used for labour induction is therefore off-label. The primary outcome is the time between placement of the device and delivery. Ad secondary outcomes are among others the cesarean delivery rate and patient satisfaction with the induction method.",[28,67,107],"Obstetric Delivery",[109],"Trial of Labour","2025-01-10",{"date":112,"type":40},"2025-01-14",{"date":114,"type":40},"2023-12-29",{"date":116,"type":20},"2026-12-28",{"name":118,"class":47},"Insel Gruppe AG, University Hospital Bern"]